Investor Hankey Don
13D/G Filings

This page shows a list of all the recent 13D/G filings made by Hankey Don . Schedule 13D is commonly referred to as a “beneficial ownership report.” The term "beneficial owner" is defined under SEC rules. It includes any person who directly or indirectly shares voting power or investment power (the power to sell the security).

When a person or group of persons acquires beneficial ownership of more than 5% of a voting class of a company’s equity securities, they are required to file a Schedule 13D within ten days after the purchase. Click the link icon to see the full transaction history.

Add This Fund
to your dashboard

Date Form Target Prev
Shares		 Current
Shares		 Change
(Percent)		 Ownership
(Percent)		 Change
(Percent)
2023-09-25 13D/A AX / Axos Financial, Inc. 901,848 2,826,576
2023-03-29 13D/A BBLG / Bone Biologics Corporation 7,678,344 7,144,395
2022-02-14 13G/A MMNFF / MedMen Enterprises Inc. 57,006,299
2021-11-01 13D/A BBLG / Bone Biologics Corporation 28,563,398 7,678,344
2020-01-17 13D/A BBLG / Bone Biologics Corporation 28,465,740 28,563,398
2019-08-08 13D/A BBLG / Bone Biologics Corporation 27,912,549 28,465,740
2019-07-17 13D/A BBLG / Bone Biologics Corporation 27,827,443 27,912,549
2019-06-21 13D/A BBLG / Bone Biologics Corporation 26,763,613 27,827,443
2019-05-24 13D/A BBLG / Bone Biologics Corporation 25,699,783 26,763,613
2019-03-26 13D/A BBLG / Bone Biologics Corporation 25,699,783
2012-11-14 13D AX / Axos Financial, Inc. 901,848